Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Net Margin (2023 - 2025)

Immunocore Holdings' Net Margin history spans 3 years, with the latest figure at 28.74% for Q4 2025.

  • For Q4 2025, Net Margin fell 51.0% year-over-year to 28.74%; the TTM value through Dec 2025 reached 8.88%, up 759.0%, while the annual FY2025 figure was 8.88%, 759.0% up from the prior year.
  • Net Margin for Q4 2025 was 28.74% at Immunocore Holdings, down from 0.17% in the prior quarter.
  • Across five years, Net Margin topped out at 10.83% in Q3 2024 and bottomed at 35.6% in Q1 2023.
  • The 3-year median for Net Margin is 21.76% (2023), against an average of 16.03%.
  • The largest YoY upside for Net Margin was 4001bps in 2025 against a maximum downside of -1100bps in 2025.
  • A 3-year view of Net Margin shows it stood at 28.12% in 2023, then decreased by 0bps to 28.23% in 2024, then fell by -2bps to 28.74% in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Net Margin are 28.74% (Q4 2025), 0.17% (Q3 2025), and 10.55% (Q2 2025).